Orforglipron CAS 2212020-52-3

Deskripsyon Product:

Non pwodwi: Orforglipron CAS 2212020-52-3

 

Sinonim:

GLP-1 agonist reseptè 1 USP/EP/BP;

LY3502970.

 

Pwopriyete Chimik ak Fizik

Aparans: Yon solid

Esè: NLT98%

Dansite: 1.50g / cm3

Solibilite: DMSO: 125 mg / mL (141.57 mM)

 

Aplikasyon: Orforglipron se yon agonist reseptè peptide -1 (GLP-1) ki sanble ak glikagòn ki sòti nan patant WO2018056453A1, Konpoze 67.

 

Nou ka bay touOrforglipron entèmedyè:

Bromo-2,6-dimethylfluorobenzene CAS 99725-44-7-3-Aminobutanenitrile hydrochloride CAS 1073666-54-2;

1,3-dietil 2-({4-bromofenil)-4-idwoksi-4-metil-6-oxocyclohexane-1,3- dikarboxylate CAS 4759-57-3;

(S)-etil-5-(2,2-dimethyltetrahydro-2H-piran-4-il)-1H-indol-2-carboxylate CAS { {10}};

(S)-1-({4-fluoro-1-metil-1H-indazol-5-il)-3-(2-({{ 8}}fluoro-3,5-dimetilfenil){{11 }}metil-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]piridin-3-il)-1 H-imidazol-2(3H)-yon sèl idroklorid CAS 2212022-57-4;

(R)-4-metil-1,3,2-dioxathiolane2,2-dyoksid CAS 1006381-03-8;

4-Bromo-3-fluoro-2-methylaniline CAS 127408-03-1.

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: orforglipron cas 2212020-52-3, manifaktirè, founisè, faktori, achte, nan stock

• On: Suzetrigine (VX-548) CAS 2649467-58-1
• Pwochen: Pevonedistat CAS 905579-51-3